The Aerobika Oscillating Positive Expiratory Pressure (OPEP) Therapy System from Monaghan Medical Corp recently earned Gold at the Medical Design Excellence Awards (MDEA). MDEA is an International Award recognizing groundbreaking products that save lives, improve patient healthcare, change the face of medical technology, and overcome design and engineering challenges. It is one of the medical technology industry’s highest honors.

The Aerobika Oscillating PEP device is a drug-free, easy to use, hand-held device designed for patients with COPD, cystic fibrosis (CF) and other respiratory conditions. Clinical evaluations conducted at Robarts Research Institute (Western University, London) demonstrated use of the device could significantly reduce breathlessness and improve the patient’s quality of life.

The award was announced at the MDEA Awards Ceremony held last month in New York City. Entries were evaluated by an impartial panel of industry experts comprised of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts.

The Aerobika Oscillating PEP device was deemed to excel in 5 evaluation criteria:

  • Manufacturing and technological innovation;
  • Design and engineering advancements;
  • Patient benefits;
  • Business benefits; and
  • Overall improvement to healthcare industry.

“When the Aerobika Oscillating PEP Therapy System was created, the goal was to develop a product that addressed an unmet need for patients suffering from serious respiratory conditions, including COPD, CF, Bronchiectasis, Post Op and any patient with a productive cough requiring a non – pharmaceutical method to assist removing secretions from the lung,” said Dom Coppolo, Monaghan’s vice president of Clinical Affairs.

“The overall goal of the device is to ensure the patient can maintain their treatments to control their symptoms, breathe easier, enjoy a better quality of life and ultimately, stay out of the hospital.”

The device is available at many leading hospitals across the United States and by prescription from a physician. More information is available on the company’s website.